| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cirmtuzumab | neurotrophic tyrosine kinase ror1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Lymphocytic Leukemia[MeSHID:D015451] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] |
63.65 | phase 2 | unknown |
| click here to return to the previous page | ||||||||